| Michael Alan Fischman, MD | |
|
8 Collins Rd, Bristol, CT 06010-3843 | |
| (860) 585-6944 | |
| (860) 585-7746 |
| Full Name | Michael Alan Fischman |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 8 Collins Rd, Bristol, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902848773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 029272 (Connecticut) | Primary |
| 208600000X | Surgery | 029272 (Connecticut) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Alan Fischman, MD 8 Collins Rd, Bristol, CT 06010-3843 Ph: (860) 585-6944 | Michael Alan Fischman, MD 8 Collins Rd, Bristol, CT 06010-3843 Ph: (860) 585-6944 |
News Archive
Curexo Technology Corporation made history on Wednesday, May 26, 2010 when its next-generation ROBODOC® Surgical System assisted Dr. William Bargar as he performed the first commercial hip replacement surgery on Warren Roberts of Davis, CA. Mr. Roberts had his left hip replacement using this robotic device in 1995 as a part of an FDA study. This recent surgery performed at Sutter General in Sacramento was for Mr. Roberts' right hip.
A review in the December issue of the journal Archives of Pathology & Laboratory Medicine by Paul Bunn Jr, MD, University of Colorado Cancer Center investigator and past president of ASCO, IASLC and AACI describes the current state of lung cancer care.
The Global Strategy for Women's and Children's Health has received about $20 billion in new money, according to a new report from The Partnership for Maternal, Newborn & Child Health (PMNCH).
Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS).
The failure of programming that sparks the death of dendritic cells - those that activate the immune system - can initiate autoimmune disease, said researchers from Baylor College of Medicine in a report that appears in the current issue of the journal Science.
› Verified 3 days ago
Kai Hans Hammerich, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 25 Newell Rd Ste D21, Bristol, CT 06010 Phone: 860-585-6944 Fax: 860-585-7746 | |
Peter Francis Daddario, MD Urology Medicare: Medicare Enrolled Practice Location: 25 Newell Rd Ste D21, Bristol, CT 06010 Phone: 860-585-6944 Fax: 860-585-7746 | |
Ariel Morley, PA Urology Medicare: Accepting Medicare Assignments Practice Location: 15 Riverside Avenue, Bristol, CT 06010 Phone: 833-424-3627 |